Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehiro Katayama

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Ophthalmology|November 24, 2012
Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications StudyRyo Kawasaki, Shiro Tanaka, Sachiko Tanaka, et al.
Journal of Atherosclerosis and Thrombosis|July 16, 2005
CLOCK/BMAL1 is involved in lipid metabolism via transactivation of the peroxisome proliferator-activated receptor (PPAR) response elementIkuo Inoue, Yuichi Shinoda, Masaaki Ikeda, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS)Hirohito Sone, Sachiko Tanaka, Shiro Tanaka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2009
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patientsToshio Ogihara, Takao Saruta, Hiromi Rakugi, et al.
Ophthalmology|August 4, 2010
Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degenerationTakashi Tsuchihashi, Keisuke Mori, Kuniko Horie-Inoue, et al.
Journal of Diabetes and Its Complications|March 22, 2016
Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications StudyShiro Tanaka, Sachiko Tanaka, Satoshi Iimuro, et al.
Endocrinology|May 13, 2017
Effects of the Activation of Three Major Hepatic Akt Substrates on Glucose Metabolism in Male MiceGota Sakai, Ikuo Inoue, Tokuko Suzuki, et al.
The New England Journal of Medicine|March 11, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesHermann Haller, Sadayoshi Ito, Joseph L Izzo, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 2, 2009
Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restorationTakanari Nakano, Ikuo Inoue, David H Alpers, et al.
Journal of Hypertension|March 2, 2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyHermann Haller, Gian C Viberti, Albert Mimran, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Ophthalmology|November 24, 2012
Risk of cardiovascular diseases is increased even with mild diabetic retinopathy: the Japan Diabetes Complications StudyRyo Kawasaki, Shiro Tanaka, Sachiko Tanaka, et al.
Journal of Atherosclerosis and Thrombosis|July 16, 2005
CLOCK/BMAL1 is involved in lipid metabolism via transactivation of the peroxisome proliferator-activated receptor (PPAR) response elementIkuo Inoue, Yuichi Shinoda, Masaaki Ikeda, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS)Hirohito Sone, Sachiko Tanaka, Shiro Tanaka, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|March 6, 2009
Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patientsToshio Ogihara, Takao Saruta, Hiromi Rakugi, et al.
Ophthalmology|August 4, 2010
Complement factor H and high-temperature requirement A-1 genotypes and treatment response of age-related macular degenerationTakashi Tsuchihashi, Keisuke Mori, Kuniko Horie-Inoue, et al.
Journal of Diabetes and Its Complications|March 22, 2016
Maximum BMI and microvascular complications in a cohort of Japanese patients with type 2 diabetes: the Japan Diabetes Complications StudyShiro Tanaka, Sachiko Tanaka, Satoshi Iimuro, et al.
Endocrinology|May 13, 2017
Effects of the Activation of Three Major Hepatic Akt Substrates on Glucose Metabolism in Male MiceGota Sakai, Ikuo Inoue, Tokuko Suzuki, et al.
The New England Journal of Medicine|March 11, 2011
Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetesHermann Haller, Sadayoshi Ito, Joseph L Izzo, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 2, 2009
Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restorationTakanari Nakano, Ikuo Inoue, David H Alpers, et al.
Journal of Hypertension|March 2, 2006
Preventing microalbuminuria in patients with diabetes: rationale and design of the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) studyHermann Haller, Gian C Viberti, Albert Mimran, et al.
Pageof 13